Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00605_DB01432> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00605_DB01432 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00605_DB01432 label "DDI between Sulindac and Cholestyramine - The bile acid sequestrant, cholestyramine, may decrease the absorption of the NSAID, sulindac. Monitor for changes in the therapeutic and adverse effects of sulindac if cholestyramine is initiated, discontinued or dose changed. Administering the two agents 2 or more hours apart may reduce, but not eliminate, the risk of this interactions. [drugbank_resource:DB00605_DB01432]" assertion.
- drugbank_resource:DB00605_DB01432 identifier "drugbank_resource:DB00605_DB01432" assertion.
- drugbank_resource:DB00605_DB01432 title "DDI between Sulindac and Cholestyramine - The bile acid sequestrant, cholestyramine, may decrease the absorption of the NSAID, sulindac. Monitor for changes in the therapeutic and adverse effects of sulindac if cholestyramine is initiated, discontinued or dose changed. Administering the two agents 2 or more hours apart may reduce, but not eliminate, the risk of this interactions." assertion.